Since February 2023, the FDA and various companies have been actively initiating recalls of eye drop...
read moreThe U.S. Food and Drug Administration (FDA) has approved clobetasol propionate ophthalmic suspension...
read moreFormycon AG and its licensing partner Klinge Biopharma GmbH announced the U.S. Food and Drug Adminis...
read moreOculis has reported positive topline results from its Phase 2 ACUITY trial evaluating OCS-05, a nove...
read moreAldeyra Therapeutics announced the receipt of a Complete Response Letter from the U.S. Food and Drug...
read moreBausch + Lomb announced that the FDA has granted approval for Miebo (perfluorohexyloctane ophthalmic...
read moreViGeneron has announced significant progress for its gene therapy candidate VG901, aimed at treating...
read moreHeidelberg Engineering announced the FDA clearance of its upgraded SPECTRALIS® OCTA Module featuring...
read moreHeidelberg Engineering has received FDA clearance for the new Epithelial Thickness Module on its Ant...
read moreThe U.S. Food and Drug Administration (FDA) has accepted a revised supplemental New Drug Application...
read more